Correlation Between Immix Biopharma and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Elevation Oncology, you can compare the effects of market volatilities on Immix Biopharma and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Elevation Oncology.
Diversification Opportunities for Immix Biopharma and Elevation Oncology
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Immix and Elevation is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Elevation Oncology go up and down completely randomly.
Pair Corralation between Immix Biopharma and Elevation Oncology
Given the investment horizon of 90 days Immix Biopharma is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Immix Biopharma is 2.3 times less risky than Elevation Oncology. The stock trades about -0.06 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 56.00 in Elevation Oncology on October 25, 2024 and sell it today you would earn a total of 10.00 from holding Elevation Oncology or generate 17.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Elevation Oncology
Performance |
| Timeline |
| Immix Biopharma |
| Elevation Oncology |
Immix Biopharma and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Elevation Oncology
The main advantage of trading using opposite Immix Biopharma and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |